In summary, CCA can alleviate LPS‐induced inflammation by modulating the NF‐κB/MAPK signaling cascade and inhibit oxidative stress by facilitating Nrf2 nuclear translocation, thereby delaying the progression of atherosclerosis (Zhao et al. 2020). The gene discussed is NFKB1; the disease is atherosclerosis.